Indivior PLC (LON:INDV) has been given a consensus recommendation of “Buy” by the seven analysts that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is GBX 419.29 ($5.30).

A number of equities research analysts have recently issued reports on INDV shares. Jefferies Group LLC restated a “buy” rating and issued a GBX 490 ($6.20) target price on shares of Indivior PLC in a research note on Thursday, May 4th. Numis Securities Ltd restated a “buy” rating and issued a GBX 490 ($6.20) target price on shares of Indivior PLC in a research note on Tuesday, April 4th. Stifel Nicolaus restated a “buy” rating and issued a GBX 500 ($6.33) target price on shares of Indivior PLC in a research note on Thursday, May 4th. Citigroup Inc. upped their target price on shares of Indivior PLC from GBX 320 ($4.05) to GBX 340 ($4.30) and gave the company a “neutral” rating in a research note on Thursday, March 2nd. Finally, Royal Bank Of Canada lowered shares of Indivior PLC to a “sector performer” rating and upped their target price for the company from GBX 370 ($4.68) to GBX 390 ($4.93) in a research note on Monday, March 13th.

ILLEGAL ACTIVITY NOTICE: This report was first reported by American Banking News and is the property of of American Banking News. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/06/13/indivior-plc-indv-given-consensus-recommendation-of-buy-by-brokerages.html.

Shares of Indivior PLC (LON INDV) traded up 0.19% during trading on Tuesday, hitting GBX 324.50. The company’s stock had a trading volume of 1,786,839 shares. The company’s market cap is GBX 2.34 billion. Indivior PLC has a 52 week low of GBX 202.81 and a 52 week high of GBX 382.30. The firm’s 50 day moving average price is GBX 326.42 and its 200-day moving average price is GBX 321.19.

Indivior PLC Company Profile

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia.

Receive News & Ratings for Indivior PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior PLC and related companies with MarketBeat.com's FREE daily email newsletter.